Benzinga | Nov 4, 2020 05:03PM EST

DiaMedica Therapeutics Q3 EPS $(0.19) Up From $(0.20) YoY

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.19) per share. This is a 5 percent increase over losses of $(0.20) per share from the same period last year.